RT Journal Article
SR Electronic
T1 Topoisomerase II alpha Expression in Breast Ductal Invasive Carcinomas and Correlation with Clinicopathological Variables
JF In Vivo
JO In Vivo
FD International Institute of Anticancer Research
SP 837
OP 840
VO 19
IS 5
A1 A. KALOGERAKI
A1 P. IEROMONACHOU
A1 M. KAFOUSI
A1 E. GIANNIKAKI
A1 T. VREKOUSSIS
A1 O. ZORAS
A1 D. TSIFTSIS
A1 G. DELIDES
A1 E. STATHOPOULOS
YR 2005
UL http://iv.iiarjournals.org/content/19/5/837.abstract
AB Topoisomerase II alpha (topo IIα) is an enzyme that in normal cells is expressed predominantly in the S/G2/M-phase of the cell cycle. In malignant cells, in vitro studies have indicated that the expression of topo II alpha is both higher and less dependent on the proliferation state in the cell. To study the expression of topo IIα and the relationship between that expression and other variables in cases of breast ductal invasive carcinomas, 50 fine-needle aspiration biopsies were performed from the same number of female patients, diagnosed cytologically and confirmed histologically after surgery. The same cases were studied immunocytochemically using monoclonal antibodies to topo IIα and Her2/neu (CB11) by the alkaline phosphatase method (APAAP). Topo IIα was found in 32 cases (64%) of the carcinomas studied. An overexpression between topo IIα and Her2/neu was found (p<0.005). A relationship between topo IIα expression, histological grade and lymph node status (LNs) was also found (p<0.005). Increased topo IIα expression seems to be related to an aggressive form of breast cancer featuring Her2 amplification and lymph node metastasis. Copyright © 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved